Trials / Terminated
TerminatedNCT06038513
Transnasal Induction of Normothermia for Neurogenic Fever
A Prospective, Open Label Clinical Trial to Evaluate the Safety and Efficacy of the COOLSTAT® Transnasal Thermal Regulating Device in Inducing Normothermia for Neurogenic Fever in an Intensive Care Setting
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- CoolTech LLC · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the efficacy of the COOLSTAT® Transnasal Thermal Regulating Device in reducing temperature in a population of febrile subjects who meet the inclusion/exclusion criteria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transnasal Thermal Regulating Device | Placement of transnasal thermal regulating device to reduce temperature in febrile patients for a period of 24 hours |
Timeline
- Start date
- 2023-11-21
- Primary completion
- 2025-08-01
- Completion
- 2025-11-30
- First posted
- 2023-09-14
- Last updated
- 2026-01-26
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06038513. Inclusion in this directory is not an endorsement.